Paloma Partners’s Tevogen Bio Holdings TVGN Stock Holding History

Paloma Partners’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200	Closed	-$103K	–	1027
2022 Q4	$103K	Hold	200	–	–	﹤0.01%	793
2022 Q3	$102K	Hold	200	–	–	﹤0.01%	819
2022 Q2	$100K	Hold	200	–	–	﹤0.01%	973
2022 Q1	$100K	Buy	+200	New	+$99.5K	﹤0.01%	1581

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paloma Partners's TVGN Position: Q1 2023 in Review

Paloma Partners sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 200 shares — an estimated $103K sold.

Paloma Partners first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $103K in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Paloma Partners reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
Paloma Partners sold 200 Tevogen Bio Holdings shares in Q1 2023, an estimated $103K.
Paloma Partners first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 4 quarters.
Paloma Partners's Tevogen Bio Holdings position peaked at $103K in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on Paloma Partners's 13F filing for Q1 2023, filed 15 May 2023.